What is the best choice for combination therapy in the management of dyslipidemia of metabolic syndrome?

dc.contributor.authorTurhan, Hasan
dc.contributor.authorYetkin, Ertan
dc.date.accessioned2024-08-04T20:15:22Z
dc.date.available2024-08-04T20:15:22Z
dc.date.issued2006
dc.departmentİnönü Üniversitesien_US
dc.description.abstract[Abstract Not Available]en_US
dc.identifier.doi10.1159/000091150
dc.identifier.endpage140en_US
dc.identifier.issn0008-6312
dc.identifier.issn1421-9751
dc.identifier.issue3en_US
dc.identifier.pmid16449809en_US
dc.identifier.scopus2-s2.0-33645467147en_US
dc.identifier.scopusqualityQ3en_US
dc.identifier.startpage139en_US
dc.identifier.urihttps://doi.org/10.1159/000091150
dc.identifier.urihttps://hdl.handle.net/11616/94340
dc.identifier.volume105en_US
dc.identifier.wosWOS:000237777600002en_US
dc.identifier.wosqualityQ2en_US
dc.indekslendigikaynakWeb of Scienceen_US
dc.indekslendigikaynakScopusen_US
dc.indekslendigikaynakPubMeden_US
dc.language.isoenen_US
dc.publisherKargeren_US
dc.relation.ispartofCardiologyen_US
dc.relation.publicationcategoryDiğeren_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.subjectDiabetes-Mellitusen_US
dc.subjectStatin Therapyen_US
dc.subjectEzetimibeen_US
dc.titleWhat is the best choice for combination therapy in the management of dyslipidemia of metabolic syndrome?en_US
dc.typeLetteren_US

Dosyalar